Anti-Mullerian Hormone levels after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in breast cancer patients

被引：0

作者：

Choi, Y. M. ^{[1
,2
]}

Shin, J. J. ^{[3
]}

Kim, H. ^{[1
]}

Lee, K. H. ^{[4
]}

Kim, T. Y. ^{[4
]}

Han, W. ^{[5
]}

Im, S. A. ^{[4
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea

[2] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea

[3] Heryoojae Womens Hosp, Fertil Ctr, Seoul, South Korea

[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[5] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea

来源：

HUMAN REPRODUCTION | 2019年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-430

引用

页码：339 / 339

页数：1

共 50 条

[1] Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients
Lee, D. Y.
Mok, C. W.
Choi, D.
HUMAN REPRODUCTION, 2017, 32 : 373 - 373
[2] Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
Dong-Yun Lee
Yeon Hee Park
Jeong Eon Lee
DooSeok Choi
Breast Cancer Research and Treatment, 2018, 171 : 649 - 656
[3] Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
Lee, Dong-Yun
Park, Yeon Hee
Lee, Jeong Eon
Choi, DooSeok
BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) : 649 - 656
[4] Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
Kim, Hee Jeong
Lee, Moo Hyun
Lee, Jeong Eon
Park, Seho
Lee, Eun Sook
Kang, Yong Joon
Shin, Hae Na
Kim, Seung Il
Lee, Jun Ho
Im, Seock Ah
Ahn, Sei Hyun
Lee, Keun Seok
Sohn, Joohyuk
Kim, Seonok
Nam, Seok Jin
Han, Wonshik
CLINICAL BREAST CANCER, 2018, 18 (05) : E1165 - E1172
[5] Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
Poggio, Francesca
Lambertini, Matteo
Bighin, Claudia
Conte, Benedetta
Blondeaux, Eva
D'Alonzo, Alessia
Dellepiane, Chiara
Buzzatti, Giulia
Molinelli, Chiara
Boccardo, Francesco
Del Mastro, Lucia
CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13
[6] Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
Shin, Jae Jun
Choi, Young Min
Jun, Jong Kwan
Lee, Kyung-Hun
Kim, Tae-Yong
Han, Wonshik
Im, Seock-Ah
JOURNAL OF BREAST CANCER, 2020, 23 (03) : 268 - 278
[7] Gonadotropin-Releasing Hormone Agonist for Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
Blumenfeld, Zeev
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3310
[8] The Protective Effects of Gonadotropin-releasing Hormone Agonist on Ovarian Functions in Breast Cancer Patients Receiving Chemotherapy
Wang, Chen
Yu, Xing-Fei
DISCOVERY MEDICINE, 2018, 25 (135) : 7 - 11
[9] The oncologic effect of a gonadotropin releasing hormone (GnRH) agonist for ovarian protection during breast cancer chemotherapy
Kim, H. J.
Lee, M. H.
Lee, J. E.
Park, S. H.
Lee, E. S.
Kang, Y-J
Lee, J. H.
Shin, H. N.
Kim, S. I.
Im, S. A.
Ahn, S. H.
Lee, K. S.
Sohn, J.
Han, W.
Nam, S. J.
CANCER RESEARCH, 2016, 76
[10] Serum Anti-Mullerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
Drakopoulos, Panagiotis
van de Vijver, Arne
Parra, Jose
Anckaert, Ellen
Schiettecatte, Johan
Blockeel, Christophe
Hund, Martin
Verhagen-Kamerbeek, Wilma D. J.
He, Ying
Tournaye, Herman
Polyzos, Nikolaos P.
FRONTIERS IN ENDOCRINOLOGY, 2019, 10

← 1 2 3 4 5 →